SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CuraGen (CRGN)
An SI Board Since March 1998
Posts SubjectMarks Bans Symbol
478 35 0 CRGN
Emcee:  Superhawk Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
453Illumina to merge with (acquire) Solexa - Message 23005223 Puts competition fornigel bates-11/13/2006
452CuraGen and TopoTarget Out-License Worldwide Rights for Preclinical HDAC Inhibitnigel bates-11/2/2006
451CuraGen Reports Third Quarter 2006 Results Thursday October 26, 7:00 am ET - Comnigel bates-10/26/2006
450CuraGen and TopoTarget Provide Update and Preliminary Data on PXD101 Clinical Denigel bates-10/26/2006
449454 Sequencing(TM) Reveals New Pathway in RNA Interference Wednesday October 25,nigel bates-10/25/2006
448Solexa is maintaining a marketcap above $300M. Surely Curagen will end up spinniMike McFarland-9/28/2006
447Motley Fool on CRGN <b>Is CuraGen Hiding a Genomic Gem?</b> ThursdaRCMac-9/28/2006
446[FGF-20 and Parkinson's Disease] >> J Neurosci. 2006 Sep 20;26(38):97tuck-9/23/2006
445Roche Applied Science and 454 Life Sciences Corporation today announced that theMike McFarland-9/11/2006
444454 Life Sciences' Genome Sequencer 20(TM) Wins R&D 100 Award August 31,Jim Oravetz-9/6/2006
443[PXD101, an HDAC inhibitor, in preclinical ovarian cancer studies] >>Mol tuck-8/25/2006
442article about possibly spinning off 454 genomeweb.comMike McFarland-8/1/2006
441CuraGen Looking at 'Strategic Options' for 454 as Unit's Revenues SoMike McFarland-7/30/2006
440finance.yahoo.com This time Curagen went down to $2 3/4 then bounced. Four timeMike McFarland-7/26/2006
439heh, heh..... two cups, you'll be wearing TWO??scaram(o)uche-7/20/2006
438Could postulate all kinds of patient groups who might benefit, but that would benigel bates-7/20/2006
437Research supported by The Hair Club for Men.scaram(o)uche-7/20/2006
436454 Life Sciences and Max Planck Institute to Sequence Neandertal Genome Thursdanigel bates-7/20/2006
435Dana Farber and 454 Life Sciences Announce Breakthrough in DNA Sequencing for Canigel bates-6/25/2006
434CuraGen Initiates Phase I Clinical Trial with CR011-vcMMAE for Metastatic Melanonigel bates-6/22/2006
433CuraGen Initiates Second Phase II Clinical Trial with Velafermin Tuesday May 30,nigel bates-5/30/2006
432Now up ~20% off the low finance.yahoo.com Gosh, I also see that a person could Mike McFarland-5/26/2006
431For the third time in the past couple years, shares have gone down to around $3Mike McFarland-5/19/2006
430454 Life Sciences and Roche Diagnostics Announce Updated Version of the Genome Snigel bates-4/26/2006
429>>was Head of Worldwide Product Development for Bayer AG from May 1998 to nigel bates-3/30/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News